129 results.
"Cognixion™ is a neurotech A.I. company building a commercially viable biosignal recognition system that moves neuroscience from the lab to market. The new artificial intelligence-powered signal processing platform translates brainwave signals via a BCI directly into communication."
"CoMind is a venture-backed startup building next-generation neural interfaces. Their non-invasive brain-computer interfaces allow communication with the brain. CoMind’s mission is to create the next computing interface, whilst simultaneously improving our understanding of the human brain and neurological disorders."
"CorTec is a young company in the field of medical engineering. We are developing the world’s most efficient implants serving as a direct interface between brain and technology.
CorTec Brain Interchange is an new brain pacemaker technology that we are offering to our customers for the treatment of neurological diseases. The completely implantable system is able to record brain activity and influence it by electrical stimulation.
The unique feature of CorTec Brain Interchange is that it is able to control itself (closed-loop technology): The system records the brain’s activity and thus the effect of its stimulation. It then aligns its further activities with the recorded data.
Neurotechnological implants currently available on the market work via externally controlled continuous stimulation of the brain. CorTec Brain Interchange determines the respective therapeutic demand in direct communication with the brain and thus allows for more gentle treatment."
"Neurobit Technologies is a digital health company bringing a paradigm shift in sleep healthcare and fitness using a suite of AI Services."
"Liquidweb is an ICT company focused on mobile and pervasive technologies applied to the areas of digital health, IoT and Robotics.
The main research area is on Artificial intelligence applied to human-computer interaction.
Liquidweb has developed BRAINCONTROL, a platform for human-computer interaction based on biofeedback. Its first application was addressed as a breakthrough Augmentative Alternative Communicator controlled by thoughts, for LIS/CLIS patients."